Novabone Products, LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Oct 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 29, 2027The maintenance fee for Novel ionically crosslinked materials and methods for production (US 9,144,629) comes due Mar 29, 2027. Unpaid by Sep 29, 2027, it lapses early.
- 3 fees due Jun 1, 2027
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,758,803 | Resorbable Macroporous Bioactive Glass Scaffold and Method of Manufacture In force · High confidence | In force | High confidence | |
| US 9,144,629 | Novel ionically crosslinked materials and methods for production In force · High confidence | In force | High confidence | |
| US 9,198,936 | Devices and Methods for the Regeneration of Bony Defects In force · High confidence | In force | High confidence | |
| US 9,199,006 | Combination Products Including Bioactive Glass and Collagen and Kits Including the Same In force · High confidence | In force | High confidence | |
| US 9,199,032 | System and Kit for Delivering Collagen Bioglass Composite Bone Grafting Materials for Regenerating Hard Tissues In force · High confidence | In force | High confidence | |
| US 8,795,702 | Devices and Methods for the Regeneration of Bony Defects In force · High confidence | In force | High confidence | |
| US 9,498,459 | Sodium containing sol-gel derived bioactive glasses and uses thereof including hemostasis In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 9,433,704 | Osteostimulative settable bone graft putty In force (reinstated) · High confidence | In force (reinstated) | High confidence |
Also on record, not counted in the 8: 2 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
8 no status recorded